What A Polygenic Risk Score Test Can Tell You?

A polygenic risk score test estimates how your combined genetic variants compare with other people’s for a specific condition. It does not diagnose disease, and it does not tell you whether you will develop one. What it gives you is a statistical estimate of inherited susceptibility — one piece of a much larger picture that includes age, lifestyle, environment, and family history.

The tests have become widely available and heavily marketed. Some of what they promise holds up. Some does not. Here is an honest breakdown of what these scores can and cannot do.

What A Polygenic Risk Score Test Can Tell You?

A polygenic risk score summarizes the combined effect of many genetic variants, each contributing a very small amount to disease risk. Most common conditions — type 2 diabetes, coronary artery disease, breast cancer, and others — are influenced by hundreds or thousands of such variants rather than one gene. The score adds up those small effects into a single number.

That number is then usually expressed relative to a reference population. A score in the top few percent means your inherited susceptibility is higher than most people’s. A score near the middle means it is roughly average. A low score means lower inherited susceptibility.

What the score does not tell you is your absolute risk. A person with a high score for a condition may still have a low chance of developing it, depending on other factors. This distinction between relative and absolute risk is where most misunderstanding happens.

How Is a Polygenic Risk Score Calculated?

The score is built from large genetic studies that compare the DNA of people with a condition to the DNA of people without it. Researchers identify variants that appear more often in one group. Each variant gets a weight based on how strongly it is associated with the condition. Your DNA is then checked against that list, and the weighted effects are summed.

The quality of the score depends heavily on the studies behind it. Three things matter:

• Sample size. Larger studies produce more reliable variant lists. Scores built from small studies tend to be unstable.
• Ancestry. Most large genetic studies have been conducted in people of European ancestry. A score built from those studies may perform poorly — sometimes very poorly — when applied to people of African, Asian, or other ancestries. This is a well-documented limitation, not a minor caveat.
• The condition itself. Scores work better for some conditions than others. They tend to perform reasonably for conditions with strong polygenic architecture, like coronary artery disease. They perform less well for conditions where environment or rare mutations play a larger role.

Two companies can produce different scores for the same person because they use different underlying studies and methods. Neither is necessarily wrong. They are answering the same question with different data.

How Useful Are These Scores Compared With Standard Risk Factors?

For most common diseases, established risk factors — age, blood pressure, smoking, cholesterol, body weight, family history — still carry substantial predictive weight. A polygenic score adds information, but it usually adds it at the margins.

That said, there are conditions where the genetic contribution is large enough that the score meaningfully improves risk prediction. Some research suggests that for coronary artery disease, adding a polygenic score to standard risk calculators can reclassify some people into higher or lower risk categories. Whether that reclassification leads to better health outcomes is still being studied. Improved prediction is not automatically improved outcomes.

For most other conditions, the added value is smaller and less established. The evidence is mixed, and results vary by condition, study population, and how the score is used.

What Can a High Score Actually Mean?

A high score means your inherited susceptibility is above average. It does not mean you will get the condition. Most people with high scores for a given disease never develop it, because risk depends on far more than genetics.

Consider two people with the same high score for type 2 diabetes. One is sedentary with a poor diet and a family history of the disease. The other is physically active and maintains a healthy weight. Their actual risk is not the same, even though their genetic starting point is.

This is the part marketing tends to blur. A high score is a reason to pay attention to modifiable risk factors. It is not a diagnosis, a destiny, or a reason to panic. And a low score is not permission to ignore those same factors — genetics is one input, not a shield.

What Are the Limitations and Risks of These Tests?

The limitations are real and worth understanding before you spend money or make decisions based on a result.

• Ancestry bias. As noted, scores derived mostly from European-ancestry studies may be far less accurate for other populations. Some companies acknowledge this. Others do not.
• Absolute risk is often unclear. Many consumer reports give a relative score without a clear absolute risk figure. Without that, it is hard to know what the number means for you personally.
• No clinical guidelines for most uses. For most conditions, there is no established clinical guideline telling doctors how to act on a polygenic score. Some clinicians use them in specific contexts, such as certain cancer risk assessments, but this is not universal practice and varies by setting.
• Psychological impact. A high score can cause anxiety. A low score can create false reassurance. Neither response is grounded in what the score actually measures.
• Privacy. Genetic data is sensitive. How companies store, share, and use it varies. Read the privacy terms before submitting a sample.

One clarification worth making: a polygenic risk score is not the same as genetic testing for single-gene mutations like BRCA1 or BRCA2. Those tests look for specific variants with large effects and established clinical guidance. Polygenic scores are a different tool with different evidence behind them. Confusing the two is common and leads to misplaced confidence in either direction.

Should You Take One?

That is a personal decision, and the honest answer is that it depends on what you plan to do with the result. If a score would prompt you to act on risk factors you were already ignoring, it may have value. If you are looking for certainty about your future health, it will not provide it.

If you are considering a test, talking with a doctor or genetic counselor first is reasonable. They can help you understand what a result would and would not mean for your specific situation. For some conditions, a score may add useful context. For others, it may add little beyond what standard risk factors already tell you.

The technology is improving. Scores are getting better as studies grow and become more diverse. But right now, for most people and most conditions, a polygenic risk score is one modest input among many — not a crystal ball.